AXGN.NASDAQAxogen, INC

Form 4: Axogen Director Sells Shares to Cover Tax Obligations from RSU Vesting

Sentiment:

Insider Transaction Report

📋All filings for Axogen, INC
🔒Login to Follow

Axogen Director Kathy Weiler sold 4,073 shares of common stock on June 9, 2025, at a weighted average price of $10.61 per share, primarily to satisfy tax obligations related to restricted stock unit vesting.

Summary

  • Kathy Johnson Weiler, a Director of Axogen, Inc. (AXGN), reported a transaction on June 9, 2025.
  • The transaction involved the sale of 4,073 shares of Axogen common stock.
  • The shares were sold at a weighted average price of $10.61 per share, with individual sale prices ranging from $10.47 to $10.61.
  • The primary purpose of the sale was to satisfy tax obligations incurred from the vesting of restricted stock units.
  • Following this transaction, Ms. Weiler directly beneficially owns 6,580 shares of Axogen common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine sale of shares to cover tax obligations arising from restricted stock unit vesting, which is a common and generally neutral event for insider holdings and does not indicate a change in company fundamentals or management confidence.

Negatives

  • The transaction represents a reduction in direct insider ownership by a director, although the reason for the sale is routine.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

  • The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends.

Stakeholder Impact

  • Shareholders: A slight reduction in direct insider ownership, though the sale is for a common and expected tax-related purpose and is unlikely to significantly impact shareholder sentiment.

Key Dates

DateDescription
06/09/2025Date of the reported transaction (sale of common stock).
06/11/2025Date the Form 4 filing was signed and submitted.

Recommendation

hold

Keywords

Axogen, AXGN, Form 4, insider trading, stock sale, director, restricted stock units, RSU, tax obligations

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.